About MuScan
MuScan is a company based in Nuenen (Netherlands) founded in 2008. It operates as a B2B. MuScan operates in a competitive market with competitors including Halo Labs, Spheryx, TACount, Nexcelom Bioscience and Biotrack, among others.
- Headquarter Nuenen, Netherlands
- SectorsHealthcare
- Website muscan.eu
Competitors of MuScan
MuScan operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Halo Labs, Spheryx, TACount, Nexcelom Bioscience and Biotrack, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| halolabs.com | 2010 | Burlingame, United States | $23.7M | – | Developer of subvisible particle analyzer for life science and materials applications | |
| spheryx.solutions | 2014 | New York, United States | $1.78M | – | Analytical instruments company developing instruments for non-destructive, quantitative measurements of suspended particles | |
| tacount.com | 2009 | Herzliya, Israel | $2.5M | – | Specializes in imaging-based technology for microbiological testing. | |
| nexcelom.com | 2003 | Lawrence, United States | – | – | Automated cell counting and imaging solutions are developed for cytometry. | |
| biotrack.nl | 2011 | Leeuwarden, Netherlands | – | – | Rapid microbial detection and identification system | |
| nanoparticleanalyzer.com | 2013 | Torrance, United States | – | 14 | Nano-particle counters are manufactured for research and biomedical uses. | |
| bioavlee.com | 2014 | Wroclaw, Poland | $536,432 | 3 | Bacteria are identified rapidly using laser diffraction and neural networks. | |
| cellometer.net | 2003 | Lawrence, United States | – | 98 | Specializes in automated cell counting and analysis expertise. | |
| micro-identification.com | 2010 | San Clemente, United States | – | – | Optical devices for rapid microbial identification in samples are manufactured. | |
| buglab.com | 2003 | Concord, United States | – | – | Offers biomass monitoring solutions for fermentation and microbial applications. |
Detailed competitors of MuScan
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to MuScan
10 companies that operate in the same segment as MuScan (Infectious Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Clinical diagnostics and drug discovery for immune diseases are provided. | 2009 | Seattle, Washington, United States | USD 419.15 M | USD 276.98 M | 619 | |
Vaccines for infectious diseases are developed using cell-free protein synthesis. | 2013 | Foster City, California, United States | USD 347 M | – | 414 | |
Portable PCR diagnostics for infectious diseases are developed. | 2010 | San Jose, California, United States | USD 386.33 M | – | – | |
Developing glucan synthase inhibitors for the treatment of fungal infections. | 1999 | Jersey City, New Jersey, United States | USD 62.65 M | USD 20.6 M | 28 | |
Sherlock Biosciences is focused on molecular diagnostics development. | 2019 | Watertown, United States | USD 111 M | – | 33 | |
Provider of diagnostic solutions for systemic infections | 2016 | San Francisco, California, United States | USD 191.47 M | – | 54 | |
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MuScan
MuScan was founded in 2008.
MuScan is headquartered in Nuenen, Netherlands. It is registered at Nuenen, Noord-brabant, Netherlands.
MuScan operates with a B2B model, focusing on providing healthcare solutions, offering diagnostic solutions, microbial detection, and rapid systems. Offers rapid microbial detection systems for accurate and quick results. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
MuScan's top competitors include Halo Labs, Spheryx and Spectradyne.